Related Experiment Video
Updated: Nov 1, 2025

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Coronavirus Disease-2019 in Children with Primary Kidney Disease: A Case series
Ashwin Meshram1, Kinnari B Vala1, Anshuman Saha1
1Department of Rediatric Nephrology, Institute of Kidney Diseases and Research Center, Ahmedabad, Gujarat, India.
Insights
Children with primary kidney disease experienced mild to moderate coronavirus disease-2019 (COVID-19). Prompt management with azithromycin and supportive care led to full recovery in these pediatric patients.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Public Health
Background:
- Comorbid illnesses are recognized risk factors for severe COVID-19.
- The clinical presentation of COVID-19 in pediatric patients with primary kidney disease remains unclear.
Observation:
- This study details the clinical profile and management of three children with primary kidney disease (nephrotic syndrome, hemolytic uremic syndrome, chronic kidney disease) diagnosed with COVID-19.
- Two immunosuppressed patients temporarily halted immunosuppressants and experienced mild illness.
- One patient with chronic kidney disease presented with moderate illness requiring oxygen support.
Findings:
- All three pediatric patients maintained normal renal function throughout their COVID-19 illness.
- Treatment with oral azithromycin and supportive care resulted in complete recovery for all patients.
- No patients required chloroquine, corticosteroids, or monoclonal antibodies.
Implications:
- COVID-19 in children with primary kidney disease may have a manageable clinical course.
- Azithromycin and supportive care appear effective for treating COVID-19 in this vulnerable pediatric population.
- Further research is warranted to understand long-term outcomes and optimal management strategies.
Abstract:
Underlying comorbid illness is a known risk factor for severe coronavirus disease-2019 (COVID-19). Clinical course of COVID-19 in children with primary kidney disease is not well understood. We present the clinical profile and management of COVID-19 in three children at a COVID hospital in India. These children had nephrotic syndrome, hemolytic uremic syndrome, and chronic kidney disease, respectively. The first two were immunosuppressed, mandating to stop their immunosuppressive medications temporarily. Both had mild course of illness. Third child presented with respiratory distress requiring oxygen support, falling into moderate disease. Renal functions were normal in all of them. They all responded well to oral azithromycin and supportive management. None of them received chloroquine, corticosteroids, or monoclonal antibodies. All three recovered without complications.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

